Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Transition Therapeutics Inc: Premium Company Profile

Published by: Datamonitor

Published: Apr. 22, 2008 - 46 Pages


Table of Contents


Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Locations and Subsidiaries
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Products & Services
Pipeline Products
AC Forecast Product Sales
Competitors and Strategic Business Relationships
Key Competitors
Key Suppliers
Key Clients
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Manufacturing
Scorecard
Overview
Scorecard Analysis
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
APPENDIX
Ask the analyst
Datamonitor consulting
Disclaimer
TABLE OF FIGURES
Figure 1: Transition Therapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
TABLE OF TABLES
Table 1: Transition Therapeutics - Key Facts
Table 2: Transition Therapeutics - Locations and Subsidiaries
Table 3: Transition Therapeutics - Year-End Share Price and Market Capitalization, 2002-2006 ($)
Table 4: Transition Therapeutics - Key Events Impacting Share Price Performance
Table 5: Transition Therapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table 6: Transition Therapeutics - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
Table 7: Transition Therapeutics - Balance Sheet, 2002-2006 ($ Mn)
Table 8: Transition Therapeutics - Cash Flow, 2002-2006 ($ Mn)
Table 9: Transition Therapeutics - In-house Pipeline Products
Table 10: Transition Therapeutics - Collaboration Products
Table 11: Transition Therapeutics - Forecast Sales, 2006-2010 ($ Mn)
Table 12: Transition Therapeutics - Key Competitors
Table 13: Transition Therapeutics - Key Suppliers
Table 14: Transition Therapeutics - Key Clients
Table 15: Transition - SWOT Analysis Summary
Table 16: Transition Therapeutics - Value Chain Analysis
Table 17: Transition Therapeutics - Scorecard
Table 18: Transition Therapeutics - Key Employees
Table 19: Transition Therapeutics - Financial and Operational Overview


Abstract

Introduction

Transition Therapeutics is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. The company’s patented drug discovery technologies have helped the company in expanding its pipeline portfolio.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

The company's clinical pipeline products include: ELND-005 being developed in collaboration with Elan for Alzheimer’s disease (Phase II), E1-I.N.T being developed in collaboration with Eli Lilly for diabetes (Phase II), HCV-I.E.T for Hepatitis C (Phase II), and GLP1-I.N.T for diabetes (Phase I). The company recognizes revenues in the form of license fees, collaboration fees and milestone payments. These primarily include revenues recognized from Ellipsis Neurotherapeutics as management fees; milestone payments from Juvenile Diabetes Research Foundation International, Elan and Eli Lilly; and license fees recognized from Novo Nordisk. Transition Therapeutics did not record any revenues during the period 2002-2004. The company’s total revenues increased from $0.1 million in 2005 to $0.3 million in 2006. The company derived 100% of its revenues as licensing fees from Novo Nordisk pursuant to its licensing agreement for Transition Therapeutics’ I.N.T technology.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization .

Please note: This is delivered as a Zip file.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008